KRKyeongmin Ryu

Kyeongmin Ryu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kyeongmin Ryu has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early Prediction of Sepsis in the Intensive Care Unit Using the GRU-D-MGP-TCN Model

    by Seunghee Lee, Geonchul Shin, Jeongseok Hwang, Yunjeong Hwang, Hyunwoo Jang, Ju Han Park, Sunmi Han, Kyeongmin Ryu, Jong-Yeup Kim

    Background: Sepsis is a life-threatening condition with significant risk to individuals, most prevalent in intensive care units (ICUs). Early diagnosis and prompt treatment are crucial to reducing sepsis-related mortality. Research on developing an artificial intelligence-based clinical decision support system for the early prediction of sepsis is underway. However, a state-of-the-art model has not yet been developed. Methods and Results: In this study, we developed a predictive model for the early detection of sepsis by leveraging advanced machine learning techniques, specifically the Gated Recurrent Unit (GRU-D) and Multitask Gaussian Process-Temporal Convolutional Network (MGP-TCN) models. This newly developed model demonstrated improved performance compared to existing results, with an area under the precision-recall curve of 0.965 (0.710) from 0.689 (0.432) and an area under the receiver operating characteristic curve of 0.994 (0.924) from 0.915 (0.828). Conclusions: This study demonstrates the potential of the GRU-D-MGP-TCN model to improve sepsis prediction in the ICU setting, thereby contributing to a significant reduction in sepsis-related mortality through timely intervention.


  • Open Access

    Time Series AI Model for Acute Kidney Injury Detection Based on a Multicenter Distributed Research Network: Development and Verification Study

    by Suncheol Heo, Eun-Ae Kang, Jae Yong Yu, Hae Reong Kim, Suehyun Lee, Kwangsoo Kim, Yul Hwangbo, Rae Woong Park, Hyunah Shin, Kyeongmin Ryu, et al.

    Background: Acute kidney injury (AKI) is a marker of clinical deterioration and renal toxicity. While there are many studies offering prediction models for the early detection of AKI, those predicting AKI occurrence using distributed research network (DRN)–based time series data are rare. Objective: In this study, we aimed to detect the early occurrence of AKI by applying an interpretable long short-term memory (LSTM)–based model to hospital electronic health record (EHR)–based time series data in patients who took nephrotoxic drugs using a DRN. Methods: We conducted a multi-institutional retrospective cohort study of data from 6 hospitals using a DRN. For each institution, a patient-based data set was constructed using 5 drugs for AKI, and an interpretable multivariable LSTM (IMV-LSTM) model was used for training. This study used propensity score matching to mitigate differences in demographics and clinical characteristics. Additionally, the temporal attention values of the AKI prediction model’s contribution variables were demonstrated for each institution and drug, with differences in highly important feature distributions between the case and control data confirmed using 1-way ANOVA. Results: This study analyzed 8643 and 31,012 patients with and without AKI, respectively, across 6 hospitals. When analyzing the distribution of AKI onset, vancomycin showed an earlier onset (median 12, IQR 5-25 days), and acyclovir was the slowest compared to the other drugs (median 23, IQR 10-41 days). Our temporal deep learning model for AKI prediction performed well for most drugs. Acyclovir had the highest average area under the receiver operating characteristic curve score per drug (0.94), followed by acetaminophen (0.93), vancomycin (0.92), naproxen (0.90), and celecoxib (0.89). Based on the temporal attention values of the variables in the AKI prediction model, verified lymphocytes and calcvancomycin ium had the highest attention, whereas lymphocytes, albumin, and hemoglobin tended to decrease over time, and urine pH and prothrombin time tended to increase. Conclusions: Early surveillance of AKI outbreaks can be achieved by applying an IMV-LSTM based on time series data through an EHR-based DRN. This approach can help identify risk factors and enable early detection of adverse drug reactions when prescribing drugs that cause renal toxicity before AKI occurs.


  • Open Access

    Development and Verification of Time-Series Deep Learning for Drug-Induced Liver Injury Detection in Patients Taking Angiotensin II Receptor Blockers: A Multicenter Distributed Research Network Approach

    by Suncheol Heo, Jae Yong Yu, Eun Ae Kang, Hyunah Shin, Kyeongmin Ryu, Chungsoo Kim, Yebin Chegal, Hyojung Jung, Suehyun Lee, Rae Woong Park, et al.

    Objectives: The objective of this study was to develop and validate a multicenter-based, multi-model, time-series deep learning model for predicting drug-induced liver injury (DILI) in patients taking angiotensin receptor blockers (ARBs). The study leveraged a national-level multicenter approach, utilizing electronic health records (EHRs) from six hospitals in Korea.Methods: A retrospective cohort analysis was conducted using EHRs from six hospitals in Korea, comprising a total of 10,852 patients whose data were converted to the Common Data Model. The study assessed the incidence rate of DILI among patients taking ARBs and compared it to a control group. Temporal patterns of important variables were analyzed using an interpretable timeseries model.Results: The overall incidence rate of DILI among patients taking ARBs was found to be 1.09%. The incidence rates varied for each specific ARB drug and institution, with valsartan having the highest rate (1.24%) and olmesartan having the lowest rate (0.83%). The DILI prediction models showed varying performance, measured by the average area under the receiver operating characteristic curve, with telmisartan (0.93), losartan (0.92), and irbesartan (0.90) exhibiting higher classification performance. The aggregated attention scores from the models highlighted the importance of variables such as hematocrit, albumin, prothrombin time, and lymphocytes in predicting DILI.Conclusions: Implementing a multicenter-based timeseries classification model provided evidence that could be valuable to clinicians regarding temporal patterns associated with DILI in ARB users. This information supports informed decisions regarding appropriate drug use and treatment strategies.


  • Open Access

    Development and Verification of a Time Series AI Model for Acute Kidney Injury Detection Based on a Multicenter Distributed Research Network (Preprint)

    by Suncheol Heo, Eun-Ae Kang, Jae Yong Yu, Hae Reong Kim, Suehyun Lee, Kwangsoo Kim, Yul Hwangbo, Rae Woong Park, Hyunah Shin, Kyeongmin Ryu, et al.

    BACKGROUND Acute kidney injury (AKI) is a marker of clinical deterioration and renal toxicity. While there are many studies offering prediction models for the early detection of AKI, those predicting AKI occurrence using distributed research network (DRN)-based time series data are rare. OBJECTIVE In this study, we aimed to detect the early occurrence of AKI by applying the interpretable LSTM-based model on a hospital EHR-based time series in patients who took nephrotoxic drugs using a DRN. METHODS We conducted a multi-institutional retrospective cohort study of data from six hospitals using a DRN. For each institution, a patient-based dataset was constructed using five drugs for AKI, and the interpretable multi-variable long short-term memory (IMV-LSTM) model was used for training. This study employed propensity score matching to mitigate differences in demographics and clinical characteristics. Additionally, the temporal attention values of the AKI prediction model's contribution variables were demonstrated for each institution and drug, with differences in highly important feature distributions between the case and control data confirmed using one-way analysis of variance. RESULTS This study analyzed 8,643 and 31,012 patients with and without AKI, respectively, across six hospitals. When analyzing the distribution of AKI onset, vancomycin showed an earlier onset (median: 12 days), and acyclovir was the slowest compared to the other drugs (median: 23 days). Our temporal deep learning model for AKI prediction performed well for most drugs. Acyclovir had the highest average area under the receiver operating characteristic curve score per drug (0.94), followed by acetaminophen (0.93), vancomycin (0.92), naproxen (0.90), and celecoxib (0.80). Based on the temporal attention values of the variables in the AKI prediction model, verified lymphocytes and calcium had the highest attention, whereas lymphocytes, albumin, and hemoglobin tended to decrease over time, and urine pH and prothrombin time tended to increase. CONCLUSIONS Early surveillance of AKI outbreaks can be achieved by applying the IMV-LSTM based on time series data through hospital electronic health records (EHR)-based DRNs. This approach can help identify risk factors and enable early detection of adverse drug reactions when prescribing drugs that cause renal toxicity before AKI occurs.